← Leaderboards
Jeffrey A Lieberman
University Of North Carolina Chapel Hill
$17,412,506
Attributed
$17,412,506
Total exposure
9
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.7M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$32,190,262 · 13
By mechanism
P50$11,929,346 · 3
N01$10,369,769 · 1
U01$5,285,057 · 3
R01$2,072,449 · 1
P30$1,730,112 · 1
M01$706,436 · 3
Top collaborators
- Joshua Tolkien Kantrowitz1 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Diana O. Perkins$14,499,789
- Thomas Scott Stroup$20,597,752
- David Lewis Penn$3,885,846
- Linmarie Sikich$18,880,212
- Gary Joseph Pielak$5,385,291
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectAntipsychotic AgentsHuman Therapy EvaluationAdolescence (12-20)SchizophreniaClinical ResearchRisperidoneMental Disorder ChemotherapySerotonin InhibitorDrug Screening /EvaluationLongitudinal Human StudyClinical TrialsBehavioral /Social Science Research TagPsychosisPatient Oriented ResearchChild Mental DisordersHaloperidolPathologic ProcessFunctional Magnetic Resonance ImagingBrain Imaging /Visualization /ScanningNeuropsychological TestsNeuropathologyMagnetic Resonance ImagingNuclear Magnetic Resonance Spectroscopy
Grant awards (34)
Human Trial of Allosteric Modulator Alpha7 Nicotinic Receptors in Schizophrenia$1,118,298
U01 · FY2015 · MH · contact PI
Pharmacologic and Clinical Testing of a D1 Agonist for Neuropsychiatric Disorders$492,247
U01 · FY2010 · MH · contact PI
Pharmacologic and Clinical Testing of a D1 Agonist for Neuropsychiatric Disorders$838,403
U01 · FY2009 · MH · contact PI
Neurobiology of Dopamine in Schizophrenia$2,069,443
P50 · FY2008 · MH · contact PI
Neurobiology of Dopamine in Schizophrenia$2,118,875
P50 · FY2007 · MH · contact PI
Neurobiology of Dopamine in Schizophrenia$2,179,245
P50 · FY2006 · MH · contact PI
Neurobiology of Dopamine in Schizophrenia$1,932,607
P50 · FY2005 · MH
Pharmacologic and Clinical Testing of a D1 Agonist for Neuropsychiatric Disorders$778,165
U01 · FY2005 · MH
COMPARATIVE EFFECTIVENESS OF ANTIPSYCHOTIC MEDICATIONS IN PATIENTS W/SCHIZOPHENI$5,026
M01 · FY2005 · RR
BRAIN MRI/MRS CHANGES IN FIRST EPISODE OF SCHIZOPHRENIA$5,026
M01 · FY2005 · RR
BRAIN MRI &MRS CHANGES IN FIRST EPISODE SCHIZOPHRENIA$537,561
R01 · FY2004 · MH
Comparative Effectiveness of Antipsychotic Medications in Patients w/Schizopheni$11,038
M01 · FY2004 · RR
Brain MRI/MRS Changes in First Episode of Schizophrenia$8,773
M01 · FY2004 · RR
Human Genetics Initiative-CATIE Schizophrenia Trial$283
M01 · FY2004 · RR
Prospective Studies of the Pathogenesis of Schizophrenia$1,848,299
P50 · FY2003 · MH
TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS)$726,583
U01 · FY2003 · MH
BRAIN MRI &MRS CHANGES IN FIRST EPISODE SCHIZOPHRENIA$528,379
R01 · FY2003 · MH
Prospective Studies of the Pathogenesis of Schizophrenia$1,780,877
P50 · FY2002 · MH
TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS)$704,147
U01 · FY2002 · MH
BRAIN MRI &MRS CHANGES IN FIRST EPISODE SCHIZOPHRENIA$501,657
R01 · FY2002 · MH
HALOPERIDOL, OLANZAPINE &RISPERIDONE IN CHILDREN W/ PSYCHOTIC DISORD$190,747
M01 · FY2002 · RR
Prospective study of the onset of schizophrenia$0
P50 · FY2002 · MH
TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS)$627,214
U01 · FY2001 · MH
BRAIN MRI &MRS CHANGES IN FIRST EPISODE SCHIZOPHRENIA$504,852
R01 · FY2001 · MH
MHCRC--NEUROSCIENCE OF MENTAL AND BEHAVIORAL DISORDERS$327,375
P30 · FY2001 · MH
HALOPERIDOL, OLANZAPINE &RISPERIDONE IN CHILDREN W/ PSYCHOTIC DISORD$294,555
M01 · FY2001 · RR
HALOPERIDOL, OLANZAPINE &RISPERIDONE IN CHILDREN W/ PSYCHOTIC DISORD$190,747
M01 · FY2001 · RR
CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVES$10,369,769
N01 · FY2000 · MH
MHCRC--NEUROSCIENCE OF MENTAL AND BEHAVIORAL DISORDERS$1,402,737
P30 · FY2000 · MH
PSYCHOBIOLOGY OF SCHIZOPHRENIA - RSDA$97,093
K02 · FY2000 · MH
HALOPERIDOL, OLANZAPINE &RISPERIDONE IN CHILDREN W/ PSYCHOTIC DISORD$241
M01 · FY2000 · RR
HALOPERIDOL, OLANZAPINE &RISPERIDONE IN CHILDREN W/ PSYCHOTIC DISORD$0
M01 · FY2000 · RR
HALOPERIDOL, OLANZAPINE &RISPERIDONE IN CHILDREN W/ PSYCHOTIC DISORD$0
M01 · FY2000 · RR
HALOPERIDOL, OLANZAPINE &RISPERIDONE IN CHILDREN W/ PSYCHOTIC DISORD$0
M01 · FY2000 · RR